Current guidelines and future directions are discussed.doi:10.1002/cncr.29447Kasi, Pashtoon MurtazaPedersen, Katrina S.McWilliams, Robert R.John Wiley & Sons, Ltd.CancerP. M. Kasi, K. S. Pedersen, and R. R. McWilliams, "BRCA2- associated pancreatic cancer and current screening guidelines,...
1.Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women. JAMA,doi:10.1001/jama.2019.8430 2. New Guidelines Expand BRCA Screening Guidelines. 3.USPSTF Formalizes Slightly Expanded BRCA Screening Recommendations. “...
According to aJAMA Oncologyreview articleby experts at Fred Hutch Cancer Center and University of Washington, newly developed national screening guidelines offer hope for identifying thecancer riskof BRCA mutations in men through genetic testing and tailored cancer screening. "Not enough men are getting...
[3] Paluch-Shimon S, Cardoso F, Sessa C, et al. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening[J]. Ann Oncol,2016,(suppl 5):v103-v110. [4] Jacobson M, Bernardini...
Purpose: We assessed the cost-effectiveness of mammography screening for women under the age of 50, from breast cancer families without proven BRCA1./BRCA2 mutations, because current criteria for screening healthy women from breast cancer families are not evidence-based. Methods: We did simulation ...
screening in the Chinese population, a consensus development group was established by the China Anti-Cancer Association Tumor Biomarker Professional Committee and the Shanghai Anti-Cancer Association Tumor Biomarker Professional Comm...
Clearly, more information is needed on whether prostate screening is effective for BRCA1 and BRCA2 carriers so that evidence-based guidelines can be established for the management of this high risk group. We look forward to the results of the IMPACT study. 162 Hereditary Cancer in Clinical ...
Current guidelines for testing stipulate that a personal or family history of cancer be present to be eligible for testing. To date, population screening in this population has not been suggested. However, this may be rational. Little is known about the appropriateness of testing guidelines for ...
Comment & Response Proposed Shift in Screening for Breast Cancer Beverly Levine, PhD; Karen Steinberg, PhD JAMA Comment & Response Proposed Shift in Screening for Breast Cancer Mary-Claire King, PhD; Amnon Lahad, MD, MPH; Ephrat Levy-Lahad, MD JAMA The...
[4]Lang G T, Shi J X, Hu X, et al. The spectrum of BRCA mutations and characteristics of BRCA‐associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next‐generation sequencing[J]...